Henson Fuerst Logo

Diabetes Drug Linked with Higher Risk of Death in Elderly

Recent studies show that elderly patients taking Avandia, or also known as rosiglitazone, have a 15% higher death rate than those taking a similar drug Actos, also known as pioglitazone.  Specifically, the drug appears to increase the risk of heart attacks, strokes or other cardiovascular events.  While additional research is suggested by the medical community, this is an important relationship that residents of nursing facilities and their families should keep in mind.  Those taking either of the drugs should consider talking with their treating physicians about the risks and benefits of these therapies, and whether other therapies should be considered as an alternative.  For more information click HERE for the full New York Times article.

Talk with us For Free

Getting legal help is only one step away.
Contact Form

Tell Us About Your Case

* Required

CALL 24/7

Our dedicated legal team is available 24/7 to assist you any urgent legal matters.

CHAT WITH US

Connect instantly with our team of experienced attorneys for any immediate concerns. Our chat feature ensures swift and confidential communication round the clock.
© 2025 Henson Fuerst. Website Design by Legal Communications.